Use of Sotrovimab in 14 Children with COVID-19: A Single-center Experience.

Sarina Kim Butzer Sandra Habbig Katrin MehlerSophie HaumannMeike Meyer Norma JungAndré Oberthür

Published in: The Pediatric infectious disease journal (2022)

Children affected by coronavirus disease 2019 (COVID-19) with preexisting comorbidities are at risk of complications. Monoclonal antibodies prevent severe COVID-19 courses in adults but data on children are scarce. Here we report on the use of Sotrovimab in 14 children at risk of severe disease treated at the University of Cologne Children's Hospital. Tolerability was good and no infusion-related reactions were seen.

Keyphrases

deep learning
coronavirus disease
young adults
machine learning
sars cov
healthcare
early onset
low dose
randomized controlled trial
clinical trial
respiratory syndrome coronavirus
risk factors
open label
double blind